PIPA5143829
SARS-CoV-2 NSP16 Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5143829-Each-of-1 | In Stock | ₹ 38,181.00 |
PIPA5143829 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 38,181.00
GST (18%): ₹ 6,872.58
Total Price: ₹ 45,053.58
Antigen
SARS-CoV-2 NSP16
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
Coronavirus; CoV; CoV-2; NSP16; rep; SARS
Immunogen
A peptide corresponding to 16 amino acids near the central domain of SARS-CoV-2 (COVID-19) NSP16 protein. The immunogen is located within 120-170 amino acids of the SARS-CoV-2 (COVID-19) NSP16 protein.
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Isotype
IgG
Applications
ELISA, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.02% sodium azide
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Target Species
Virus
Form
Liquid
Related Products
Description
- Predicted reactivity based on immunogen sequence: SARS-CoV NSP16 protein: (88%) Severe Acute Respiratory Syndrome (SARS), an emerging disease characterized by atypical pneumonia, has recently been attributed to a novel coronavirus (SARS-CoV)
- The nucleocapsid protein (N) was one of the structural proteins of SARS-CoV (N, S, sE, M)
- The severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid (N) protein is the most abundant protein in the virus-infected cells
- The SARS-CoV-2 S gene has 76% amino acid similarity to the SARS-CoV S gene, and nonsynonymous mutations developed in the S protein as the SARS-CoV epidemic developed, reports have shown that the crystal structure of the SARS-CoV-2 nucleocapsid protein is similar to those of previously described coronavirus N proteins, but their surface electrostatic potential characteristics are distinct.